Adani Enterp.

2611.2 -19.00

Adani Ports

1431.1 -12.80

Apollo Hospitals

7565 124.00

Asian Paints

2430.9 11.50

Axis Bank

1171.1 -4.20

CORPORATE INFORMATION   
Aarti Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524348
INE767A01016
136.1848045
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIDRUGS
28.26
4445.98
EPS(TTM)
Face Value()
Div & Yield %
17.11
10
0.21
Detailed Quotes
Last Price() 483.85 arrowupp
Jul 03,2025 EOD
Today's Change( ) 0.25 (0.05%) arrowupp
Open( ) 491.25
Prev Close( ) 483.60
Volume 30,447.00
Today's Range( ) 491.25 - 477.45
52-Week Range( ) 634.90 - 312.50
Buy (Size) N.A
Sell (Size) N.A
Company Background
Incorporation Year 1984
Registered Office Plot No N-198 MIDC Tarapur,Pamtembhi Village Palghar Tal,
Thane,
Maharashtra-401506
Telephone 91-22-24072249
Fax 91-22-24073462/24070144
Chairman C V Gogri
Managing Director Prakash M Patil
Company Secretary Rushikesh Deole
Auditor Gokhale & Sathe
Face Value 10
Market Lot 1
Listing BSE,NSEBSE,NSE
Registrar MUFG Intime India Pvt Ltd
C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083
Board of Directors
CMD & CEO
Managing Director
Joint Managing Director
Executive Director
Non Executive Director
Independent Director
Chairman Emeritus
Independent Director
Company Sec. & Compli. Officer
Balance Sheet
Particulars (Sources Of Funds)Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Mar 2020
( Cr)
Mar 2019
( Cr)
Share Capital 91.9492.6092.6093.2023.3023.58
Reserves Total 1083.271021.70879.57766.41598.49494.99
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1175.211114.30972.17859.61621.79518.57
Secured Loans 365.66436.24449.11219.77250.36347.25
Unsecured Loans 109.0699.2470.25115.96127.75123.26
Total Debt474.72535.48519.36335.73378.11470.51
Other Liabilities2.913.1517.4229.3933.6823.25
Total Liabilities1652.841652.931508.951224.731033.581012.33
APPLICATION OF FUNDS :
Gross Block 1274.901141.551112.471049.30991.25922.44
Less : Accumulated Depreciation 552.60507.07463.05418.78379.68336.77
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 722.30634.48649.42630.52611.57585.67
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress221.62160.7559.6215.9510.9632.37
Producing Properties0.000.000.000.000.000.00
Investments 29.9728.6228.0324.3220.3818.92
Current Assets, Loans & Advances
Inventories 441.77477.73488.46390.38307.41227.71
Sundry Debtors 643.95801.68711.64503.99464.34436.90
Cash and Bank Balance3.822.682.213.813.854.85
Loans and Advances 91.4867.4570.8861.9649.7765.55
Total Current Assets1181.021349.531273.19960.13825.36735.00
Less : Current Liabilities and Provisions
Current Liabilities 445.02467.44452.95336.03356.39270.68
Provisions 4.036.762.591.282.141.43
Total Current Liabilities & Provisions449.06474.20455.53337.30358.53272.11
Net Current Assets731.97875.33817.66622.82466.83462.89
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.000.000.000.000.000.00
Deferred Tax Liability69.7368.3770.0474.9778.5988.48
Net Deferred Tax-69.73-68.37-70.04-74.97-78.59-88.48
Other Assets16.7122.1124.266.092.420.97
Total Assets1652.841652.921508.941224.731033.571012.34
Contingent Liabilities242.23191.39178.21151.0287.8074.05
Profit and Loss
Particulars(INCOME)Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Mar 2020
( Cr)
Mar 2019
( Cr)
Sales Turnover 2266.912497.972251.171914.891634.921454.25
Excise Duty0.000.000.000.000.000.00
Net Sales2266.912497.972251.171914.891634.921454.25
Other Income 4.182.234.779.699.446.28
Stock Adjustments -26.776.7277.949.0853.94-19.05
Total Income2244.322506.922333.881933.661698.301441.48
EXPENDITURE :
Raw Materials 1476.421723.251558.471148.991099.82945.98
Power & Fuel Cost151.64153.45126.0595.64101.0482.14
Employee Cost 70.2064.3057.1755.6052.6547.23
Other Manufacturing Expenses 191.24182.71171.26138.99122.62103.91
Selling & Administrative Expenses 73.9589.2589.7576.7059.3950.37
Miscellaneous Expenses 7.525.685.246.725.402.83
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure1970.962218.642007.951522.641440.921232.46
Operating Profit273.36288.28325.94411.02257.38209.02
Interest 33.2136.1823.0525.7135.7441.00
Gross Profit240.15252.10302.89385.31221.64168.02
Depreciation47.6747.2947.3947.6046.6740.39
Profit Before Tax192.48204.81255.50337.71174.97127.63
Tax49.6053.2565.5084.5049.5531.92
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.00-1.25-5.00-4.50-10.258.45
Reported Net Profit141.88152.81195.00257.71135.6787.26
Extraordinary Items 0.000.000.000.176.352.54
Adjusted Net Profit141.88152.81195.00257.54129.3284.72
Adjustment below Net Profit -13.320.00-51.64-69.90-26.90-0.48
P & L Balance brought forward947.13818.86704.26565.52475.07399.36
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 23.3824.5428.7649.0718.3211.06
P & L Balance carried down1052.31947.13818.86704.26565.52475.07
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %10.0010.0010.0025.0020.0010.00
Dividend Per Share(Rs)1.001.001.002.502.001.00
Earnings Per Share-Unit Curr15.4316.5021.0627.6558.2337.00
Earnings Per Share(Adj)-Unit Curr15.4316.5021.0627.6514.569.25
Book Value-Unit Curr127.83120.34104.9992.23266.86219.90
Book Value(Adj)-Unit Curr127.83120.34104.9992.2366.7254.97
Quarterly Results
 
Quarters
ParticularsMar 2025 ( Cr)Dec 2024 ( Cr)Sep 2024 ( Cr)
Gross Sales622.96514.54543.09
Other Operating Income0.000.000.00
Other Income 1.7111.370.38
Total Income624.67525.91543.47
Total Expenditure 534.31454.29483.55
PBIDT90.3671.6259.92
Interest 7.487.577.17
PBDT82.8864.0552.75
Depreciation12.2112.0211.86
Tax9.6912.008.50
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.501.502.00
Reported Profit After Tax61.4838.5330.39
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item61.4838.5330.39
EPS (Unit Curr.)6.744.223.33
EPS (Adj) (Unit Curr.)6.744.223.33
Calculated EPS (Unit Curr.)6.744.223.33
Calculated EPS (Adj) (Unit Curr.)6.744.223.33
Calculated EPS (Ann.) (Unit Curr.)26.9416.8913.32
Calculated EPS (Adj) (Ann.) (Unit Curr.)26.9416.8913.32
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.0010.000.00
Equity91.2791.2791.27
Reserve & Surplus0.000.001068.06
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)14.5013.9211.03
PBDTM(%)13.3012.459.71
PATM(%)9.877.495.60
Financial Ratios
   ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.440.510.470.480.74
Long Term Debt-Equity Ratio0.180.140.150.220.33
Current Ratio1.521.431.471.451.23
Fixed Assets1.882.222.081.881.71
Inventory4.935.175.125.496.11
Debtors3.143.303.703.963.63
Interest Cover Ratio6.806.6612.0814.145.90
PBIDTM (%)12.0611.5414.4821.4615.74
PBITM (%)9.969.6512.3718.9812.89
PBDTM (%)10.5910.0913.4520.1213.56
CPM (%)8.368.0110.7715.9411.15
APATM (%)6.266.128.6613.468.30
ROCE (%)13.6515.2420.3832.1920.60
RONW (%)12.3914.6521.2934.7923.79
Share Price
Year
Jun 2025
May 2025
Apr 2025
Mar 2025
Feb 2025
Jan 2025
Share Prices Of 2024
Dec 2024
Nov 2024
Oct 2024
Sep 2024
Aug 2024
Jul 2024
Jun 2024
May 2024
Apr 2024
Mar 2024
Feb 2024
Jan 2024
Share Prices Of 2023
Dec 2023
Nov 2023

DJIA 44498.76
-17.19 -0.04%
S&P 500 6247.07
28.06 0.45%
HANG SENG 24069.95
-151.47 -0.63%
×
Ask Your Question
close
refresh